Human Antibodies
Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology, along with factors that modulate host antibody repertoire and effectiveness, such as vaccines, infectious agents, and microbiome. This includes fundamental research, applied science and clinical applications.
Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.
Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology, along with factors that modulate host antibody repertoire and effectiveness, such as vaccines, infectious agents, and microbiome. This includes fundamental research, applied science and clinical applications. Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.
| Mark Glassy | UC San Diego, USA |
| Dimitrios P. Bogdanos | University of Thessaly, Greece |
| Robert M. Anthony | Massachusetts General Hospital, USA |
| Dimitrios P. Bogdanos | University of Thessaly, Greece |
| Dennis R. Burton | The Scripps Research Institute, USA |
| Paul Carter | Genentech, Inc., USA |
| Ricard Cervera | University of Barcelona, Spain |
| Stefan Dubel | Technische Universitat Braunschweig, Germany |
| Gilad Halpert | Zabludowicz Center for Autoimmune Diseases, Israel |
| Michael Hust | Technische Universitat Braunschweig, Germany |
| Angray S. Kang | Queen Mary University of London, UK |
| Renate Kunert | Universität für Bodenkultur, Austria |
| Alois B. Lang | GeNeuro SA, Switzerland |
| James W. Larrick | Regenerative Sciences Institute, USA |
| Julian Ma | St. George's University of London, UK |
| James D. Marks | San Francisco General Hospital, USA |
| Sherie Morrison | UCLA, USA |
| David Naor | The Hebrew University of Jerusalem, Israel |
| Paul W. H. I. Parren | Lava Therapeutics, The Netherlands |
| Carlo Perricone | University of Perugia, Italy |
| Andreas A. Plückthun | University of Zurich, Switzerland |
| Matthew D. Scharff | The Albert Einstein College of Medicine, USA |
| Yehuda Shoenfeld | Tel-Aviv University, Israel |
| Sachdev Sidhu | University of Waterloo, Canada |
| Lim Theam Soon | Universiti Sains Malaysia, Malaysia |
| Jamie B. Sprangler | Johns Hopkins University, USA |
| Leonidas Stamatatos | Fred Hutchinson Cancer Research Center, USA |
| Michael Steinitz | The Hebrew University, Israel |
| Mohammad Taheri | Jena University Hospital, Germany |
| Jean-Luc Teillaud | French Institute of Health and Medical Research, France |
| Louis M. Weiner | Georgetown Lombardi Comprehensive Cancer Center, USA |
| Gregory Winter | Trinity College, UK |
| K. Dane Wittrup | Massachusetts Institute of Technology, USA |
| Susan Zolla-Pazner | Icahn School of Medicine at Mount Sinai, USA |